Affiliation:
1. Department of Pharmacy, Integral University, Dasauli, Kursi Road, Lucknow, 226026, India
Abstract
Abstract:
Ursolic acid (UA) has been utilized to improve memory-related cognitive processes and
intellectual functions. This study aims to examine the ethnobotanical uses, phytochemical composition,
toxicity, and central nervous system activities of UA. It promotes learning and memory and
has biological effects against Alzheimer's disease, Parkinson's disease, and cognitive impairment,
according to pharmacological investigations. UA did not cause any death, abnormal body weight,
or pathological diseases at any of the test doses. Furthermore, no behavioral, neurotoxin, coagulation,
haematological, or clinical chemistry changes were seen as a result of UA treatment. UA is
also used as a cosmeceutical product to improve skin functions. This article examines all
knowledge that has become available at this time for revealing the chemistry of the current has
been extensively investigated based on the data, resulting in UA derivatives with improved potency,
bioavailability, and stability being used to treat a number of non-communicable diseases. The
pharmacological activity of UA has been exploited to improve learning and memory and treat depression,
emotional stress, fatigue, anxiety, insomnia, Alzheimer’s disease, Parkinson’s disease,
epilepsy, and schizophrenia. The effects of UA on the central nervous system detailed in this review.
The majority of UA studies have been preclinical evaluations of cellular mechanisms in the
central nervous system, and more translational clinical research is needed to assess the drug's safety
and efficacy, as well as its favorable, biodistribution, which could be targeted using different
pathways and administration routes. Several in vitro and in vivo studies have investigated the
pharmacological properties of UA reporting neuroprotective effects and improvements in cognitive
function. These effects are attributed to its antioxidant, antiapoptotic, and anti-inflammatory
actions.
Publisher
Bentham Science Publishers Ltd.
Reference65 articles.
1. Fuentes Santos A.; Queiroz Souza M.M.; Bach Pauli K.; Ratti da Silva G.; Wolff Marques M.; Alvarez Auth P.; Bacopa monnieri: Historical aspects to promising pharmacological actions for the treatment of central nervous system diseases. Bol Latinoam Caribe Plantas Med Aromat 2022,21(2)
2. Pejin B.; Jovanović K.; Mojović M.; Savić A. New and highly potent antitumor natural products from marine-derived fungi: Covering the period from 2003 to 2012. Curr Top Med Chem 2013,13(21),2745-2766
3. Katz L.; Baltz R.H.; Natural product discovery: Past, present, and future. J Ind Microbiol Biotechnol 2016,43(2-3),155-176
4. Geerlofs L.; He Z.; Xiao S.; Xiao Z.C.; Repeated dose (90 days) oral toxicity study of ursolic acid in Han-Wistar rats. Toxicol Rep 2020,7,610-623
5. Liu W.; Li Q.; Hu J.; Wang H.; Xu F.; Bian Q.; Application of natural products derivatization method in the design of targeted anticancer agents from 2000 to 2018. Bioorg Med Chem 2019,27(23)